ClearPoint Neuro Inc

ClearPoint Neuro Inc

CLPT

Get informed when a big investor buys or sells

+ Follow
Market Cap$532.91M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
ClearPoint Neuro IncClearPoint Neuro Inc-17.6--154%18.53.4
$16.00

Target Price by Analysts

13.7% downsideClearPoint Neuro Target Price DetailsTarget Price
$-10.52

Current Fair Value

156.8% downside

Overvalued by 156.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$532.91 Million
Enterprise Value$560.91 Million
Dividend Yield$- (-)
Earnings per Share$-0.9
Beta1.31
Outstanding Shares29,546,889

Return

Return on Equity-154.27%ROE
Return on Assets-31.11%
Return on Invested Capital-31.55%

Valuation & Multiples

P/E Ratio-17.59P/E Ratio
PEG-30.07PEG
Price to Sales18.53Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue13.81
Enterprise Value to EBIT-21.18
Enterprise Value to Net Income-20
Total Debt to Enterprise0.11
Debt to Equity3.37Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 13, 2026
EPS Estimate
$-0.28
Average shareholder expectation
Revenue Estimate
$11.97 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 11, 2026
EPS Estimate
$-0.27
Average shareholder expectation
Revenue Estimate
$12.73 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.5508 7.83%
Total Calls335,900 4.61%
Total Puts185,000 8.42%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %45.89% 6.13%
Total Invested$118.31M 23.48%
Investors Holding125 1.00%

ESG Score

No data

About ClearPoint Neuro Inc